Roche Aktie

316,30 EUR +3,40 EUR +1,09 %

16:54:03

L&S

298,40 CHF +3,10 CHF +1,05 %

17:39:06

SWX

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.249,37 Mrd. EUR

KGV24,60Div. Rendite3,80%

WKN855167

ISINCH0012032048

SymbolRHHVF

Roche Aktien News

Sortieren:Datum Meistgelesen

08.12.24Roche Holding AGFive-year results confirm Roche’s Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma

05.12.24Roche Holding AGFDA accepts supplemental Biologics License Application for Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

05.12.24GlobeNewswireFDA accepts supplemental Biologics License Application for Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

02.12.24ZacksThe Zacks Analyst Blog Highlights Roche, Poseida Therapeutics, Merck, AstraZeneca and Novartis

26.11.24ZacksRoche to Acquire CAR-T Cell Therapy Focused Poseida for $1.5B

26.11.24Business TimesRoche to acquire cell therapy maker Poseida Therapeutics in US$1.5 billion deal

26.11.24GlobeNewswireRoche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

26.11.24Roche Holding AGRoche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

26.11.24Roche Holding AGRoche reports update on Phase III SKYSCRAPER-01 study results

26.11.24GlobeNewswireRoche reports update on Phase III SKYSCRAPER-01 study results

25.11.24PR NewswireRoche receives FDA approval for first companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with ZIIHERA

12.11.24PR NewswireFlare Therapeutics Announces Strategic Discovery Collaboration with Roche to Address Previously Undrugged Transcription Factor Targets in Oncology

05.11.24GlobeNewswireRoche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH 2024

05.11.24Roche Holding AGRoche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH 2024

31.10.24GlobeNewswireRoche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease

31.10.24Roche Holding AGRoche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease

31.10.24Roche Holding AGNew England Journal of Medicine publishes landmark phase III results for Roche’s Itovebi, showing more than doubling of progression-free survival in certain type of HR-positive advanced breast cancer

31.10.24GlobeNewswireNew England Journal of Medicine publishes landmark phase III results for Roche’s Itovebi, showing more than doubling of progression-free survival in certain type of HR-positive advanced breast cancer

28.10.24Irish TimesMan missing in Wexford Harbour named locally as Brandon Roche (20)

23.10.24Roche Holding AG[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months

23.10.24GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months

22.10.24ZacksThe Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi

18.10.24GlobeNewswireRoche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study

18.10.24Roche Holding AGRoche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study

18.10.24PR NewswireRoche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY

14.10.24ZacksRoche Wins FDA Nod for Breast Cancer Drug in First-Line Setting

14.10.24GlobeNewswireMajority of children with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate

14.10.24Roche Holding AGMajority of children with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate

11.10.24GlobeNewswireFDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation

11.10.24Roche Holding AGFDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation

10.10.24GlobeNewswireRoche obtains CE certification for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY

10.10.24Roche Holding AGRoche obtains CE certification for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY

09.10.24Business TimesRoche will boost in-China production for local market: CEO

08.10.24PR NewswireSurvey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public

07.10.24BenzingaDavid Roche Warns Of Market Instability From Fed's 50-Basis Point Cut: 'US Economy Is Robust...Does Not Need Rock Bottom Interest Rates'

01.10.24ZacksRoche Ramps Up Breast Cancer Pipeline With Regor's CDK Inhibitors

30.09.24BenzingaRoche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential

30.09.24Financial TimesRoche plans to launch drugs and slash development costs

26.09.24Roche Holding AGPositive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis

Roche News

Roche News: auf dieser Seite finden Sie alle Roche News und Nachrichten zur Roche Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Roche News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Roche News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.